{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:07:54Z","timestamp":1790356074772,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s10147-026-03155-3","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T15:40:54Z","timestamp":1785166854000},"page":"2460-2469","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Germline pathogenic variants in Japanese adolescents and young adults with advanced solid tumors: a nationwide tumor\u2013normal paired sequencing study"],"prefix":"10.1007","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1652-1436","authenticated-orcid":false,"given":"Kota","family":"Ishioka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akito","family":"Dobashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eri","family":"Habano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asami","family":"Kuga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keika","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Arakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Minoura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ippei","family":"Fukada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masumi","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akemi","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshimi","family":"Takano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunji","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arisa","family":"Ueki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makiko","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"key":"3155_CR1","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3322\/caac.21585","volume":"69","author":"AG Close","year":"2019","unstructured":"Close AG, Dreyzin A, Miller KD et al (2019) Adolescent and young adult oncology-past, present, and future. CA Cancer J Clin 69:485\u2013496. https:\/\/doi.org\/10.3322\/caac.21585","journal-title":"CA Cancer J Clin"},{"key":"3155_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16067-1","volume":"11","author":"S Akhavanfard","year":"2020","unstructured":"Akhavanfard S, Padmanabhan R, Yehia L et al (2020) Comprehensive germline genomic profiles of children, adolescents, and young adults with solid tumors. Nat Commun 11:2206. https:\/\/doi.org\/10.1038\/s41467-020-16067-1","journal-title":"Nat Commun"},{"key":"3155_CR3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1136\/jmg-2023-109269","volume":"61","author":"NA Carvalho","year":"2023","unstructured":"Carvalho NA, Santiago KM, Maia JML et al (2023) Prevalence and clinical implications of germline pathogenic variants in cancer predisposing genes in young patients across sarcoma subtypes. J Med Genet 61:61\u201368. https:\/\/doi.org\/10.1136\/jmg-2023-109269","journal-title":"J Med Genet"},{"key":"3155_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-10333-x","volume":"7","author":"SH Chan","year":"2017","unstructured":"Chan SH, Lim WK, Ishak NDB et al (2017) Germline mutations in cancer predisposition genes are frequent in sporadic sarcomas. Sci Rep 7:10660. https:\/\/doi.org\/10.1038\/s41598-017-10333-x","journal-title":"Sci Rep"},{"key":"3155_CR5","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1200\/PO.19.00224","volume":"4","author":"X Liu","year":"2020","unstructured":"Liu X, Takata S, Ashikawa K et al (2020) Prevalence and spectrum of pathogenic germline variants in Japanese patients with early-onset colorectal, breast, and prostate cancer. JCO Precis Oncol 4:183\u2013191. https:\/\/doi.org\/10.1200\/PO.19.00224","journal-title":"JCO Precis Oncol"},{"key":"3155_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06581-8","volume":"9","author":"Y Momozawa","year":"2018","unstructured":"Momozawa Y, Iwasaki Y, Parsons MT et al (2018) Germline pathogenic variants of 11 breast cancer genes in 7,051 Japanese patients and 11,241 controls. Nat Commun 9:4083. https:\/\/doi.org\/10.1038\/s41467-018-06581-8","journal-title":"Nat Commun"},{"key":"3155_CR7","doi-asserted-by":"publisher","first-page":"4279","DOI":"10.1200\/JCO.22.02378","volume":"41","author":"HM Seagle","year":"2023","unstructured":"Seagle HM, Keller SR, Tavtigian SV et al (2023) Clinical multigene panel testing identifies racial and ethnic differences in germline pathogenic variants among patients with early-onset colorectal cancer. J Clin Oncol 41:4279\u20134289. https:\/\/doi.org\/10.1200\/JCO.22.02378","journal-title":"J Clin Oncol"},{"key":"3155_CR8","doi-asserted-by":"publisher","first-page":"112258","DOI":"10.18632\/oncotarget.22733","volume":"8","author":"A Hirasawa","year":"2017","unstructured":"Hirasawa A, Imoto I, Naruto T et al (2017) Prevalence of pathogenic germline variants detected by multigene sequencing in unselected Japanese patients with ovarian cancer. Oncotarget 8:112258\u2013112267. https:\/\/doi.org\/10.18632\/oncotarget.22733","journal-title":"Oncotarget"},{"key":"3155_CR9","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1016\/j.jtho.2025.06.005","volume":"20","author":"H Cho","year":"2025","unstructured":"Cho H, Shiraishi K, Sunami K et al (2025) Genomic profiles of pathogenic and moderate-penetrance germline variants associated with risk of early onset lung adenocarcinoma. J Thorac Oncol 20:1626\u20131638. https:\/\/doi.org\/10.1016\/j.jtho.2025.06.005","journal-title":"J Thorac Oncol"},{"key":"3155_CR10","doi-asserted-by":"publisher","first-page":"17020","DOI":"10.3390\/ijms242317020","volume":"24","author":"K Horackova","year":"2023","unstructured":"Horackova K, Janatov\u00e1 M, Kleibl Z et al (2023) Early-onset ovarian cancer <30 years: What do we know about its genetic predisposition? Int J Mol Sci 24:17020. https:\/\/doi.org\/10.3390\/ijms242317020","journal-title":"Int J Mol Sci"},{"key":"3155_CR11","doi-asserted-by":"publisher","first-page":"18394","DOI":"10.1002\/cam4.6445","volume":"12","author":"S Hao","year":"2023","unstructured":"Hao S, Zhao X, Fan Y et al (2023) Prevalence and spectrum of cancer predisposition germline mutations in young patients with common late-onset cancers. Cancer Med 12:18394\u201318404. https:\/\/doi.org\/10.1002\/cam4.6445","journal-title":"Cancer Med"},{"key":"3155_CR12","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1158\/2159-8290.CD-22-0417","volume":"12","author":"T Kohno","year":"2022","unstructured":"Kohno T, Kato M, Kohsaka S et al (2022) C-CAT: the national data center for cancer genomic medicine in Japan. Cancer Discov 12:2509\u20132515. https:\/\/doi.org\/10.1158\/2159-8290.CD-22-0417","journal-title":"Cancer Discov"},{"key":"3155_CR13","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1158\/2767-9764.CRC-23-0018","volume":"3","author":"T Satake","year":"2023","unstructured":"Satake T, Kondo S, Tanabe N et al (2023) Pathogenic germline variants in BRCA1\/2 and p53 identified by real-world comprehensive cancer genome profiling tests in Asian patients. Cancer Res Microbiol 3:2302\u20132311. https:\/\/doi.org\/10.1158\/2767-9764.CRC-23-0018","journal-title":"Cancer Res Microbiol"},{"key":"3155_CR14","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1007\/s10147-024-02554-8","volume":"29","author":"T Yamaguchi","year":"2024","unstructured":"Yamaguchi T, Ikegami M, Aruga T et al (2024) Genomic landscape of comprehensive genomic profiling in patients with malignant solid tumors in Japan. Int J Clin Oncol 29:1417\u20131431. https:\/\/doi.org\/10.1007\/s10147-024-02554-8","journal-title":"Int J Clin Oncol"},{"key":"3155_CR15","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1111\/cas.70071","volume":"116","author":"K Watanabe","year":"2025","unstructured":"Watanabe K, Ogawa M, Shinozaki-Ushiku A et al (2025) Real-world data analysis of genomic alterations detected by a dual DNA\u2013RNA comprehensive genomic profiling test. Cancer Sci 116:1984\u20131995. https:\/\/doi.org\/10.1111\/cas.70071","journal-title":"Cancer Sci"},{"key":"3155_CR16","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1111\/cas.13969","volume":"110","author":"K Sunami","year":"2019","unstructured":"Sunami K, Ichikawa H, Kubo T et al (2019) Feasibility and utility of a panel testing for 114 cancer-associated genes in a clinical setting: a hospital-based study. Cancer Sci 110:1480\u20131490. https:\/\/doi.org\/10.1111\/cas.13969","journal-title":"Cancer Sci"},{"key":"3155_CR17","unstructured":"Pharmaceuticals and Medical Devices Agency (PMDA) (2026) OncoGuide\u2122 NCC Oncopanel System. . Accessed June 7 https:\/\/www.pmda.go.jp\/PmdaSearch\/kikiDetail\/ResultDataSetPDF\/480585_23000BZX00398000_A_06_01. Accessed June 7, 2026"},{"key":"3155_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s10038-025-01389-z","volume":"71","author":"E Habano","year":"2026","unstructured":"Habano E, Ogawa M, Watanabe K et al (2026) Germline pathogenic variants detected by GenMineTOP: insight from a nationwide tumor\/normal paired comprehensive genomic profiling test, in Japan. J Hum Genet 71:1\u201311. https:\/\/doi.org\/10.1038\/s10038-025-01389-z","journal-title":"J Hum Genet"},{"key":"3155_CR19","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1001\/jamaoncol.2020.6252","volume":"7","author":"NJ Samadder","year":"2021","unstructured":"Samadder NJ, Riegert-Johnson D, Boardman L et al (2021) Comparison of universal genetic testing vs. guideline-directed targeted testing for patients with hereditary cancer syndrome. JAMA Oncol 7:230\u2013237. https:\/\/doi.org\/10.1001\/jamaoncol.2020.6252","journal-title":"JAMA Oncol"},{"key":"3155_CR20","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1111\/cas.14919","volume":"112","author":"M Funato","year":"2021","unstructured":"Funato M, Tsunematsu Y, Yamazaki F et al (2021) Characteristics of Li-Fraumeni syndrome in Japan; a review study by the special committee of JSHT. Cancer Sci 112:2821\u20132834. https:\/\/doi.org\/10.1111\/cas.14919","journal-title":"Cancer Sci"},{"key":"3155_CR21","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.jhep.2018.01.009","volume":"68","author":"CP Wardell","year":"2018","unstructured":"Wardell CP, Fujita M, Yamada T et al (2018) Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations. J Hepatol 68:959\u2013969. https:\/\/doi.org\/10.1016\/j.jhep.2018.01.009","journal-title":"J Hepatol"},{"key":"3155_CR22","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.jhep.2022.09.025","volume":"78","author":"Y Okawa","year":"2023","unstructured":"Okawa Y, Iwasaki Y, Johnson TA et al (2023) Hereditary cancer variants and homologous recombination deficiency in biliary tract cancer. J Hepatol 78:333\u2013342. https:\/\/doi.org\/10.1016\/j.jhep.2022.09.025","journal-title":"J Hepatol"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-026-03155-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-026-03155-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-026-03155-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:50:32Z","timestamp":1790355032000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-026-03155-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":22,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["3155"],"URL":"https:\/\/doi.org\/10.1007\/s10147-026-03155-3","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]},"assertion":[{"value":"1 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and was approved by the Institutional Review Boards of the Japanese Foundation for Cancer Research (JFCR; IRB no. 2025-KB-059) and the Saitama Cancer Center (IRB no. 2181). Data use was authorized by the C-CAT Data Utilization Review Board (approval no. CDU2023-036E03).","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The requirement for additional written informed consent for this retrospective analysis was waived by the relevant institutional review boards because this study used de-identified data obtained through the C-CAT database.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}]}}